Chris Bray

Chris Bray has a diverse work experience in various roles within the biotechnology industry. Chris started their career as a Junior Post Doctoral Research Fellow at the Reproductive Biology and Genetics group in the Department of Medicine at the University of Birmingham, UK in 1998. Chris then moved on to work as a Postdoctoral Researcher at the Department of Human Anatomy and Cell Biology at UC Davis from 2000 to 2005.

Following their research positions, Chris worked as an Assistant Cell Biologist at UC Davis from 2005 to 2007. Chris then joined the University of California, Berkeley as an Associate Research Specialist in the Department of Molecular and Cell Biology, Division of Neurobiology, where they developed a novel molecular imaging technique to track protein-protein interactions during synaptic transmission from 2007 to 2011.

In 2011, Chris transitioned to the biotechnology industry and became a Regulatory Affairs Specialist at Accuray, specializing in product complaint management. Chris was responsible for investigating and resolving product safety and quality issues for the CyberKnife robotic radiosurgery system.

In 2013, Chris joined Novartis Vaccines and Diagnostics, Inc. as a Quality Assurance Specialist II, where they managed manufacturing deviations and implemented CAPAs and change control records for multiple recombinant protein products. Chris continued working in quality assurance as a Senior Quality Assurance Specialist at Grifols Diagnostic Solutions from 2016 to 2017, focusing on complaint handling and product quality systems for automated blood typing and genotyping systems.

From 2017 to 2019, Chris worked as a Senior Regulatory Affairs Specialist at Becton Dickinson Biosciences. In this role, they were responsible for creating, submitting, and maintaining regulatory submissions and technical documentation for various business units. Chris also reviewed and approved labeling, advertising, and promotional materials related to the products.

Currently, Chris holds the position of QA supervisor at 4D Molecular Therapeutics, where they oversee quality assurance processes.

Overall, Chris Bray has demonstrated expertise in regulatory affairs, quality assurance, research, and product complaint management throughout their career in the biotechnology industry.

Chris Bray received their education from the University of Reading. Chris completed a BSc Hons degree in Pathobiology with Chemistry from 1990 to 1993. Later, they pursued a PhD in Biochemistry and Physiology from 1993 to 1998 at the same university. Additionally, Chris Bray obtained several certifications. In 2013, they received the RAC certification from the Regulatory Affairs Certification Program and the RAC-US certification from the Regulatory Affairs Professionals Society (RAPS). In 2022, they obtained certifications in Developing Business Acumen, Building Inclusive Work Communities, and Strategies to Foster Inclusive Language at Work from LinkedIn.